LINC-ROR and neoplasm: Another experiment with sorafenib showed a positive correlation between sorafenib and linc-ROR expression in both tumor cells and extracellular vesicles, exhibiting linc-ROR-dependent effects on tumor-initiating cells and chemoresistance [127].